Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions

NCT01523093 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ondansetron

Sponsor

Ranbaxy Laboratories Limited